Report Scope & Overview:
The Ambulatory Surgical Centers Market Size was valued at USD 101.85 billion in 2022, and is expected to reach USD 187.13 billion by 2030, and grow at a CAGR of 7.9% over the forecast period 2023-2030.
ASCs are cutting-edge medical facilities where highly skilled physicians and nurses perform surgery in fully equipped operating rooms. These facilities generally serve individuals who do not require hospitalisation. The treatment can be performed beyond the clinic, and the patient can be delivered when the operation is finished. Ambulatory surgical centers are an excellent choice for folks who cannot afford significant medical bills. Ambulatory surgical facilities are outpatient surgery centers where patients can receive surgery on the same day as admission without having to stay overnight. Diagnostic and preventative treatments are available at these sites. Ambulatory surgical centers perform cataract surgery, minor joint repair, abdominal hernia repair, gall bladder removal, skin therapy, and other operations on the same day.
To get more information on Ambulatory Surgical Centers Market - Request Sample Report
Ambulatory surgery centers, or ASCs, are modern outpatient surgery centers that specialised in same-day surgical procedures such as diagnostic and preventative procedures. It has transformed the outpatient experiences of millions of Americans by providing a more convenient alternative to outpatient operations performed in hospitals. It does so by proving a long track record of high-quality care and positive patient outcomes. There are fewer complications with these treatments, and they require less time in the hospital.
MARKET DYNAMICS
DRIVERS
Ambulatory Surgical Centers (ASCs) are turning out to be more famous.
Healthcare expenditures are out of control, and it's time to do something about it.
ASCs are increasingly turning to IT for help.
RESTRAINTS
Investing much on infrastructure and deploying at a high cost
OPPORTUNITIES
Cloud-based solutions are in higher demand.
Patient-centered care is becoming more popular.
CHALLENGES
Issues concerning interoperability
IMPACT OF COVID-19
COVID-19's pandemic has a significant impact on the market for ambulatory surgery centers. Many countries have imposed lockdown restrictions and postponed non-essential surgeries to prevent the COVID-19 virus from spreading in the community.
This key choice resulted in a considerable decrease in the number of ambulatory visits, harmed the global ambulatory surgery center market's growth significantly.
By-Products & services
Clinical solutions, non-clinical solutions, and HCIT outsourcing services are the three segments of the ambulatory surgery centers market. The market for ambulatory surgical centers was dominated by the clinical solutions category. An essential driver impelling the interest for medical services supplier arrangements is the need to control rising medical services expenses and increment the productivity of medical care administrations by diminishing clinical blunders.
By Components
Services, software, and hardware make up the market for ambulatory surgery centers. The largest market share was held by the services sector. This is because of the expanded interest for consultancy and reevaluating of various medical care tasks, for example, income cycle the executives, Electronic Health Records (EHR) organization, and extortion recognition, as well as the presentation of confounded programming and the prerequisite for programming coordination and interoperability.
By Specialty
The market for ambulatory surgical centers is divided into single-specialty and multi-specialty facilities. The multi-specialty category of the ambulatory surgery centers market held the highest proportion of the market. The huge share of this market might be attributable to the large number of surgical procedures performed in these institutions and the fact that these procedures are reimbursed.
KEY MARKET SEGMENTS
By-Products & services
Clinical its solutions
EHRS
Non-clinical healthcare its solutions
HCIT outsourcing services
By Components
Services
Software
Hardware
By Specialty
Single Specialty
Multi-specialty
.png)
Need any customization research on Ambulatory Surgical Centers Market - Enquiry Now
REGIONAL ANALYSIS
North America, Europe, Asia Pacific, and the Rest of the World are the regions in which the ambulatory surgery centers (ASCs) market is divided. In the Asia Pacific, ASCs are a relatively recent concept. However, rising healthcare costs due to the frequency of chronic illnesses, the ageing population, excessive healthcare spending, and increased hospital readmissions have prompted the establishment of outpatient centers.
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
KEY PLAYERS:
Some of the major key players of Ambulatory Surgical Centers Market ae as follows: AmSurg, Surg Center Development, United Surgical Partners, Team Health Holdings, Surgery Partners, Mednax, Surgical Care Affiliates, Tenet Healthcare, Envision Healthcare Holdings, Suprabha Surgi care and Other Players
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 101.85 Billion |
| Market Size by 2030 | US$ 187.13 Billion |
| CAGR | CAGR of 7.9% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By-Products & services (Clinical its solutions, EHRS, Non-clinical healthcare its solutions, HCIT outsourcing services) • By Components (Services, Software, Hardware) • By Specialty (Single Specialty, Multi-specialty) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | AmSurg, Surg Center Development, United Surgical Partners, Team Health Holdings, Surgery Partners, Mednax, Surgical Care Affiliates, Tenet Healthcare, Envision Healthcare Holdings, and Suprabha Surgi care. |
| DRIVERS | • Ambulatory Surgical Centers (ASCs) are turning out to be more famous. • Healthcare expenditures are out of control, and it's time to do something about it. • ASCs are increasingly turning to IT for help. |
| RESTRAINTS | • Investing much on infrastructure and deploying at a high cost |
Ans: The Ambulatory Surgical Centers market is expected grow at a CAGR of 7.9% over the forecast period 2023-2030.
Ans: The Ambulatory Surgical Centers Market size was value at US$ 101.85 billion in 2022.
Ambulatory Surgical Centers Market is divided into three segments By-Products & services, By Components, and By Specialty
The Ambulatory Surgical Centers Market is dominated by the Asia Pacific.
The market for ambulatory surgical centers was dominated by the clinical solutions category.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of Ukraine ware
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Ambulatory Surgical Centers Market Segmentation, By-Products & services
8.1 Clinical its solutions
8.2 EHRS
8.3 Non-clinical healthcare its solutions
8.4 HCIT outsourcing services
9. Ambulatory Surgical Centers Market Segmentation, By Components
9.1 Services
9.2 Software
9.3 Hardware
10. Ambulatory Surgical Centers Market Segmentation, By Specialty
10.1 Single Specialty
10.2 Multi-specialty
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12.Company Profiles
12.1 Philips Healthcare
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 Carestream Health
12.3 Agfa Healthcare
12.4 eClinical works
12.5 Hewlett-Packard Enterprise
12.6 E-MDS, Inc.
12.7 GE Healthcare
12.8 McKesson Corporation
12.9 Athenahealth, Inc.
12.10 Orion Health.
13.Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The DNA Synthesis Market size was estimated USD 2.9 billion in 2022 and is expected to reach USD 12.2 billion by 2030 at a CAGR of 19.7% during the forecast period of 2023-2030.
The Clinical Trial Imaging Market Size was valued at USD 925.01 million in 2022, and is expected to reach USD 1818 million by 2030 and grow at a CAGR of 8.8% over the forecast period 2023-2030.
The Softgel Capsule Market Size was valued at USD 7.21 billion in 2022 and is expected to reach USD 12.97 billion by 2030, and grow at a CAGR of 7.6% over the forecast period 2023-2030.
The Multiple Sclerosis (MS) Market size was valued at USD 23.2 billion in 2022 and is expected to reach USD 28.21 billion by 2030 and grow at a CAGR of 2.2% over the forecast period of 2023-2030.
The Scanning electron microscopes Market Size was valued at USD 4.12 billion in 2022 and is expected to reach USD 8.16 billion by 2030, and grow at a CAGR of 8.9% over the forecast period 2023-2030.
The Hip Replacement Market Size was valued at USD 7.22 Bn in 2022 and is expected to reach USD 10.50 Bn by 2030 and grow at a CAGR of 5.1% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2023 All Rights Reserved by SNS Insider Pvt Ltd
